Nuffield Health, the UK's largest healthcare charity, has announced the appointment of Colonel Dame Clare Dutton as its new Clinical Services Director. Dame Clare brings a wealth of experience from both military and civilian healthcare, notably having played a crucial role in the establishment of the NHS Nightingale hospitals during the height of the COVID-19 pandemic.
Dame Clare's distinguished career spans three decades in the British Army, where she rose through the ranks as a nurse. Her military service included deployments to various operational theatres, providing critical medical care in challenging environments. Following her military career, she transitioned into senior leadership roles within the NHS, gaining extensive experience in strategic healthcare planning and delivery.
Her involvement in the NHS Nightingale hospitals project was a defining moment in recent UK healthcare history. These temporary critical care facilities were rapidly constructed across the country to cope with the anticipated surge in COVID-19 patients, demonstrating an unprecedented level of national mobilisation and collaboration. Dame Clare's expertise in logistics, planning, and clinical operations was vital in transforming exhibition centres into fully functional hospitals in a short timeframe.
In her new role at Nuffield Health, Dame Clare will be responsible for overseeing the clinical governance, quality, and safety across the charity's extensive network of hospitals, fitness and wellbeing centres, and rehabilitation services. This appointment signals Nuffield Health's commitment to strengthening its clinical leadership and leveraging top-tier expertise to enhance patient care and service delivery.
Nuffield Health operates a wide range of services designed to promote health and wellbeing, from preventative care to complex surgical procedures. The organisation, as a charity, reinvests its profits into its facilities and services, aiming to improve the health of the nation. The addition of Dame Clare to their leadership team is expected to further bolster their clinical standards and operational efficiency.